About 1 result found for searched term "197723-00-5" (0.136 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M29074 | BOLD-100 | DNA/RNA Synthesis |
| NKP-1339; IT-139; KP-1339 | ||
| BOLD-100 (NKP-1339; IT-139) is the first-in-class ruthenium-based anticancer agent in development against solid cancer with limited side effects. BOLD-100 induces G2/M cell cycle arrest, blockage of DNA synthesis, and induction of apoptosis via the mitochondrial pathway. BOLD-100 has a high tumor targeting potential, strongly binds to serum proteins such as albumin and transferrin and activates in the reductive tumor milieu. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
